Nutriband Inc. (NTRB)
NASDAQ: NTRB · Real-Time Price · USD
8.13
+0.48 (6.27%)
At close: Sep 18, 2026, 4:00 PM EDT
8.32
+0.19 (2.34%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Nutriband Revenue
Nutriband had revenue of $437.51K in the quarter ending July 31, 2026, a decrease of -29.71%. This brings the company's revenue in the last twelve months to $1.62M, down -37.25% year-over-year. In the fiscal year ending January 31, 2026, Nutriband had annual revenue of $2.04M, down -4.81%.
Revenue (ttm)
$1.62M
Revenue Growth
-37.25%
P/S Ratio
61.09
Revenue / Employee
$124,437
Employees
13
Market Cap
98.83M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2026 | 2.04M | -102.89K | -4.81% |
| Jan 31, 2025 | 2.14M | 54.22K | 2.60% |
| Jan 31, 2024 | 2.09M | 5.71K | 0.27% |
| Jan 31, 2023 | 2.08M | 657.46K | 46.23% |
| Jan 31, 2022 | 1.42M | 478.45K | 50.70% |
| Jan 31, 2021 | 943.70K | 573.06K | 154.61% |
| Jan 31, 2020 | 370.65K | 125.36K | 51.11% |
| Jan 31, 2019 | 245.29K | - | - |
| Jan 31, 2018 | - | - | - |
| Jan 31, 2017 | - | - | - |
| Jan 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Seer, Inc. | 14.22M |
| Atara Biotherapeutics | 6.19M |
| NeurAxis | 5.32M |
| Cardiff Oncology | 508.00K |
| Fractyl Health | 3.00K |
NTRB News
- 11 days ago - Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit - GlobeNewsWire
- 12 days ago - Nutriband receives notice of publication from USPTO - TheFly
- 12 days ago - Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch - GlobeNewsWire
- 5 weeks ago - Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight - GlobeNewsWire
- 4 months ago - Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference - GlobeNewsWire
- 5 months ago - Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast - GlobeNewsWire
- 5 months ago - Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch - GlobeNewsWire
- 6 months ago - Nutriband’s Kinesiology Tapes approved for distribution and sale in Costa Rica - TheFly